Price of Gemtuzumab/Gemtuzumab (MYLOTARG)

Gemtuzumab ozogamicin/Gemtuzumab (MYLOTARG)Gemtuzumab ozogamicin is a drug used to treat acute myeloid leukemia (AML). AML is a type of leukemia caused by abnormal proliferation of white blood cells in the bone marrow. Gemtuzumab/Gemtuzumab is a monoclonal antibody drug. Its mechanism of action is by binding to specific antigens on the surface of AML cells, prompting the immune system to attack and kill these cancer cells.

Gemtuzumab/Gemtuzumab is not currently on the market in China, so it cannot be included in medical insurance. Patients cannot purchase it domestically and need to purchase gemtuzumab through overseas channels/Gemtuzumab. Gemtuzumab abroad/The only gemtuzumab available is Pfizer's original drug, which is expensive. The cheaper ones are mainly Turkish original drugs, which cost 45 000yuan, and the price of the original drug in Hong Kong, China is around 65,000yuan, and the ingredients and efficacy of the original drug are consistent.

Gemtuzumab/Gemtuzumab was initially used in the treatment of AML and was briefly withdrawn from the market, but was later re-approved. It is often used to treat AML patients who have relapsed or are unable to tolerate traditional treatments. Gemtuzumab/Gemtuzumab can be used as a single agent or in combination with other chemotherapy drugs.

Please note that drug use and treatment options may vary depending on the patient's specific situation and must be evaluated and guided by a physician. Gemtuzumab/Gemtuzumab may cause some side effects, including problems related to the immune system, so patients need to be closely monitored while using it.

Additionally, drug information may change over time, so if you or someone you know is considering gemtuzumab or other medicines, it is important to consult a health care professional for the most current treatment recommendations and information.